Drug Type Small molecule drug |
Synonyms |
Mechanism 5-HT receptor antagonists(Serotonin (5-HT) receptor antagonists), D2 receptor antagonists(Dopamine D2 receptor antagonists), D3 receptor antagonists(Dopamine D3 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H27ClN2O3 |
InChIKeyQHLRKDSRGUZHSH-SFHVURJKSA-N |
CAS Registry246517-66-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizophrenia | Phase 1 | GB | - |